Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
82
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Common Cold

Conditions

Common Cold, Pharyngitis, Tonsillitis

Trial Timeline

Nov 1, 2003 โ†’ Mar 1, 2005

About Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo

Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo is a approved stage product being developed by Bayer for Common Cold. The current trial status is completed. This product is registered under clinical trial identifier NCT01465009. Target conditions include Common Cold, Pharyngitis, Tonsillitis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01465009ApprovedCompleted